Google TrendMONTEZ SWEAT (1000+) — Bears DE Montez Sweat suspended 2 days for drug violation
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Motixafortide and G-CSF t" (10 stories)

Top Headline Story

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial
Lead StoryNaturegeneral
Apr 17, 2023

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5uNi11UUJPakk3Zi1nMlBqX0hkVDFmTlQtSjNHVDVVT0FRZTVibEpUS3laRWZ1SUpoeTJIbWZmV1J5ekZiTzVxcDdMU1U0dHdLUWFLMmNTQ2lTT3NLYjFB?oc=5" target="_blank">Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
1000+19m ago

montez sweat

Bears DE Montez Sweat suspended 2 days for drug violation

1000+29m ago

rob lowe

Daily Wire's 'Confession': Details Revealed For James Franco, Rob Lowe Film

500+29m ago

tanner hudson

Bengals tight end Tanner Hudson out for season with torn pec

200+29m ago

frozen frenzy

The top reason to watch every NHL team in the Frozen Frenzy

Search Results for "Motixafortide and G-CSF t"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

9 stories displayed
Motixafortide May Improve Stem Cell Transplants for People with Multiple Myeloma
National Cancer Institute (.gov)general

Motixafortide May Improve Stem Cell Transplants for People with Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNazZIMVdsMWlMV1czc3ZrNTh4X052cW5LcjFiSUNQWjNhcVFzd2hfdGZVWXg2SUJSd2dfVDRYVENZczNSV0VwTnVCZldvOE03cEd0UUJ3Z01TUzNVNncxVGFEUHJGLXRuNVRXN1lyUS13YnhtaldlTjREMElGYUFaa0JEWG1aMEhpVUo0UEd5VjdUUmkwcHU1VUpFSGxMa090ZUMwSEI3d3BuS3UtUDFzaklR?oc=5" target="_blank">Motixafortide May Improve Stem Cell Transplants for People with Multiple Myeloma</a>  <font color="#6f6f6f">National Cancer Institute (.gov)</font>

Investigational drug may improve stem cell transplantation for multiple myeloma patients
WashU Medicinegeneral

Investigational drug may improve stem cell transplantation for multiple myeloma patients

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxNX19wZm55cThnMVhOelFXY3BjUFF1amFvRWxoZ2hiVUpXUWFIb3BmLUxLcFQ1RWhFZUlOTE1qWHlYNHBCNXRVVEd0ZWMzbHU1UjJaZlZUSVBQTkg5anlxdjVxS0MwVlJ0WUxmQmMzNVlMU3BtZWd2aGd2aUw1RUxGaEN4Ynloc3cxRFE0Qzd4bThIYmFaWVgwd1ZUN1ZJQ2pSeGdxcmFJMTFvNFJwMkt6UDBSbmN6NUNMWll2SlJR?oc=5" target="_blank">Investigational drug may improve stem cell transplantation for multiple myeloma patients</a>  <font color="#6f6f6f">WashU Medicine</font>

FDA Approves Aphexda to Aid in HST Mobilization in Patients With Multiple Myeloma
Targeted Oncologytech

FDA Approves Aphexda to Aid in HST Mobilization in Patients With Multiple Myeloma

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNZkxFR1J5U0RSaVExX2ZwdE5Hd25VQXB2RUdiX0JNdHlKaWlIZGpOTVJ1aW4wQXdpazZveVpZTzhIYXlSUUpXNkRTbGJaekNxYlZqdXIzYUxqV3I1X3BMMkM2OWhldDNGRHNOWURFXzIycFZKb2ZXS1dRSjd0RThPb19nQ2VSSWxrYnRQd1ZrSDNNZmdBMDBxMXo3S2U2VjVpbHdORndMSEJDb0w3WXBkclRHZEo?oc=5" target="_blank">FDA Approves Aphexda to Aid in HST Mobilization in Patients With Multiple Myeloma</a>  <font color="#6f6f6f">Targeted Oncology</font>

Comparing stem cell mobilization with chemotherapy and cytokine (G-CSF) versus cytokine alone in myeloma patients (MOCCCA): a randomized phase II, open-label, non-inferiority trial
Naturegeneral

Comparing stem cell mobilization with chemotherapy and cytokine (G-CSF) versus cytokine alone in myeloma patients (MOCCCA): a randomized phase II, open-label, non-inferiority trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE83ZmhFbElzWHk4dWQweWpoc00za0E0Nkt4enNLa0ROZkQwQmRaNnAzQktnRzVsWHd5MWltSE0tU2ZKYzg2amozMDVjWFpPejZvaVdmYTViZkd6SVJFaWlV?oc=5" target="_blank">Comparing stem cell mobilization with chemotherapy and cytokine (G-CSF) versus cytokine alone in myeloma patients (MOCCCA): a randomized phase II, open-label, non-inferiority trial</a>  <font color="#6f6f6f">Nature</font>

Aphexda Plus Filgrastim Boosts Stem Cell Mobilization in Patients With Myeloma
Cure Todaygeneral

Aphexda Plus Filgrastim Boosts Stem Cell Mobilization in Patients With Myeloma

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxQNFJyZ2NYX2lsYXdleU5XQnFTdVlJR3BEUlhmM1FGMlRLenVkYUp3TjZCTmU3SDZYOUZ4dFUzMkRWY2dXR0lEQ3VHR2VQZ0JqZlpNSnd6RDIxZ3dlbzlYejdzMEVsNldMX3lTU2thcVNFendfbXpPblZLUTNIOFFLMzVBcmVkSmJ3cXBBZlRqOVptbkM0RVhuTVpkTVgxRVNDZF94SUotSmFDWEhwREE?oc=5" target="_blank">Aphexda Plus Filgrastim Boosts Stem Cell Mobilization in Patients With Myeloma</a>  <font color="#6f6f6f">Cure Today</font>

Motixafortide for stem cell mobilization to be tested in SCD |...
Sickle Cell Disease Newsgeneral

Motixafortide for stem cell mobilization to be tested in SCD |...

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQVDd2bXVBUElfaVVVMTdnbF9NVG92dTNGNWRuUWMxSkNXYjAtY01fWVoya3dxQVdrRWpHSWdRb0hvaUtESWNzakRGWnFQZ2p4Q3E5bHlTV1lhdmdmTGZHUWVPTmhnaTQ2OHJzTURHVUQtYUVHQzBIVUk3a2d2WmJnRVVuQ2VqRXR6V0w0SmtXam9IYnkzbk1QLTFWaFAzcVMzLVdGV2RiRmRDbVRhN05WdA?oc=5" target="_blank">Motixafortide for stem cell mobilization to be tested in SCD |...</a>  <font color="#6f6f6f">Sickle Cell Disease News</font>

FDA Approves Aphexda for Use in Stem Cell Mobilization
Managed Healthcare Executivegeneral

FDA Approves Aphexda for Use in Stem Cell Mobilization

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNWTNncHhZbE5zc2xTdDdKaDVpYl9MMjc2WlFvYXYzSnVld244ZVNEamQ1dGVfWS1LTWhuMUE2RDJEa1FJa1JnNE0ycnNGazBTVFVERHRybjhLOVBYRzhoR2VLcWNwOTZtdjVjb2JKTU4xdGVHNHpEbm04NXN0dHJDQWU5MzQ5eGtZQjlNZ0VvQ1RBcGFHZUlfejAzNk1TSlR6c1Z6YQ?oc=5" target="_blank">FDA Approves Aphexda for Use in Stem Cell Mobilization</a>  <font color="#6f6f6f">Managed Healthcare Executive</font>

Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma
Naturegeneral

Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFAxaWw0S0FxZTlxd1R6MTNRWTVUcVMyNlZZQXpDRkNIZmlibWZDLWpJRF8zNWlxUXBpcGcweU5pUEZTdmJPRkozZVRmTGdtWnBCQzB3bS1rVWt5OGM4c0JJ?oc=5" target="_blank">Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myeloma</a>  <font color="#6f6f6f">Nature</font>

Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis
Naturegeneral

Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5WSEhfWjZGeXBxNlFmOHR5LXN1SENtXzU2TVJjLW1Id0J5SHhEZnh6dG9uN0JGaWxBTUMxczRWMWQzb1FxZmQ2bHhaRGlnY1BDWEk2dm5CV1pVOE5rVkcw?oc=5" target="_blank">Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis</a>  <font color="#6f6f6f">Nature</font>

"Motixafortide and G-CSF t" — Live Google News Trends & Headlines